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ABSTRACT  23 
Table 1. Cohort characteristics by walking pace 
  Walking pace 
 Overall  Slow  
(<3 miles.h-1) 
Average 
(3-4 miles.h-1) 
Brisk  
(>4 miles.h-1) 
Socio-demographics     
Total n 318,185 14,793 164,236 139,156 
Sex (females), n(%) 174,006 (54.7) 8,483 (57.3) 89,847 (54.7) 75,676 (54.4) 
Age (years), mean (SD) 56.0 (8.14) 58.2 (7.73) 56.8 (8.08) 54.9 (8.11) 
Deprivation index tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
109,884 (34.5) 
108,397 (34.1) 
99,904 (31.4) 
 
3,511 (23.7) 
4,465 (30.2) 
6,817 (46.1) 
 
55,566 (33.8) 
56,017 (34.1) 
52,653 (32.1) 
 
50,807 (36.5) 
47,915 (34.4) 
40,434 (29.1) 
Ethnicity  
   Whites 
   Others/mixed 
   South Asians 
   Blacks 
   Chinese    
 
302,067 (94.9) 
4,614 (1.5) 
5,655 (1.8) 
4,871 (1.5) 
978 (0.3) 
 
13,090 (88.5) 
425 (2.9) 
721 (4.9) 
447 (3.0) 
110 (0.7) 
 
154,468 (94.1) 
2,607 (1.6) 
3,595 (2.2) 
2,930 (1.8) 
636 (0.3) 
 
134,509 (96.7) 
1,582 (1.1) 
1,339 (1.0) 
1,494 (1.1) 
232 (0.1) 
Employment status  
   Employed 
   Retired 
   Looking after home/family 
   Unable to work 
   Unemployed 
   Voluntary work 
   Student  
 
193,277 (60.7) 
102,224 (32.1) 
9,524 (3.0) 
5,588 (1.8) 
5,133 (1.6) 
1,518 (0.5) 
921 (0.3) 
 
5,521 (37.3) 
6,238 (42.2) 
476 (3.2) 
2,090 (14.1) 
352 (2.4) 
60 (0.4) 
56 (0.4) 
 
94,593 (57.6) 
58,070 (35.4) 
4,905 (3.0) 
2,572 (1.6) 
2,899 (1.8) 
760 (0.4) 
437 (0.2) 
 
93,163 (67.0) 
37,916 (27.3) 
4,143 (3.0) 
926 (0.6) 
1,882 (1.3) 
698 (0.5) 
428 (0.3) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
180,226 (56.6) 
107,853 (33.9) 
30,106 (9.5) 
 
7,256 (49.1) 
5,344 (36.1) 
2,193 (14.8) 
 
90,937 (55.4) 
56,856 (34.6) 
16,443 (10.0) 
 
82,033 (59.0) 
45,653 (32.8) 
11,470 (8.2) 
Obesity-related markers     
BMI (kg.m-2), mean (SD) 27.0 (4.50) 30.9 (6.26) 27.8 (4.55) 25.7 (3.71) 
BMI Categories, n (%) 
   Underweight  (<18.5 kg.m-2) 
   Normal weight (18.5-24.9 kg.m-2) 
   Overweight (25.0 to 29.9 kg.m-2) 
   Obese (≥30.0 kg.m-2) 
 
1,594 (0.5) 
111,470 (35.0) 
137,007 (43.1) 
68,114 (21.4) 
 
51 (0.3) 
2,309 (15.6) 
5,019 (33.9) 
7,414 (50.2) 
 
549 (0.3) 
45,855 (27.9) 
73,907 (45.0) 
43,925 (26.8) 
 
994 (0.7) 
63,306 (45.5) 
58,081 (41.7) 
16,775 (12.1) 
Waist Circumference (cm), mean 
(SD) 
89.2 (13.0) 98.3 (14.9) 91.1 (12.9) 86.0 (11.9) 
Central Obesity, n (%) 96,080 (30.2) 8,861 (59.9) 60,191 (36.7) 27,028 (19.4) 
% Body fat, mean (SD) 30.9 (8.43) 36.0 (9.25) 32.1 (8.41) 28.9 (7.84) 
Fitness and Physical activity     
Fitness (METs), mean (SD) 9.72 (2.77) 8.33 (2.48) 9.32 (2.67) 10.3 (2.79) 
Grip strength (Kg), mean (SD) 31.1 (10.9) 26.4 (11.0) 30.5 (10.9) 32.3 (10.8) 
Time spent walking (min.day-1), 
mean (SD) 
53.2 (56.2) 43.3 (50.0) 53.5 (57.3) 53.9 (55.5) 
Moderate intensity PA (min.day-1), 
mean (SD) 
45.0 (54.8) 40.9 (52.0) 45.1 (55.1) 45.2 (54.7) 
Vigorous intensity PA (min.day-1), 
mean (SD) 
21.1 (27.4) 18.8 (28.2) 20.3 (27.4) 22.1 (27.3) 
Total PA (METs.min.week-1), mean 
(SD) 
2,860.7 
(3,052.4) 
2,053.6 
(2,503.5) 
2,774.4 
(3,012.1) 
3,048.4 
(3,133.2) 
Physical inactivity, n (%) 39,360 (17.1) 2,214 (25.5) 21,231 (18.3) 15,915 (15.2) 
TV-viewing (h.day-1) 2.67 (1.49) 3.45 (1.96) 2.83 (1.49) 2.40 (1.37) 
Dietary intakes     
Alcohol intake (% of TE), mean (SD) 5.27 (6.50) 4.30 (6.68) 5.14 (6.59) 5.47 (6.39) 
Fruit & Vegetables intake 
(portion.day-1), mean (SD)  
338.4 (1.93.0) 328.8 (216.9) 327.4 (190.8) 352.4 (192.1) 
Oily fish (portion.day-1), mean (SD) 1.66 (0.92) 1.57 (0.98) 1.63 (0.92) 1.71 (0.92) 
Processed meat intake (portion.day-
1), mean (SD) 
1.84 (1.06) 1.97 (1.12) 1.91 (1.05) 1.76 (1.06) 
Red meat intake (portion.day-1), 
mean (SD) 
2.08 (1.41) 2.23 (1.63) 2.13 (1.42) 2.00 (1.37) 
Health status     
Diabetes, n (%) 12,449 (3.9) 1,771 (12.0) 7,665 (4.7) 3,013 (2.2) 
Systolic blood pressure (mmHg), 
mean (SD) 
137.6 (18.6) 140.3 (18.7) 138.9 (18.7) 135.9 (18.4) 
CVD medication, n (%) 73,389 (23.1) 6,399 (43.2) 43,223 (26.3) 23,767 (17.1) 
Health self-rating, n (%) 
   Excellent  
   Good  
   Fair 
   Poor 
 
61,704 (19.4) 
194,547 (61.1) 
54,972 (17.3) 
6,962 (2.2) 
 
554 (3.8) 
5,374 (36.3) 
6,224 (42.1) 
2,641 (17.8) 
 
23,028 (14.0) 
103,870 (63.2) 
34,116 (20.8) 
3,222 (2.0) 
 
38,122 (27.4) 
85,303 (61.3) 
14,632 (10.5) 
1,099 (0.8) 
  
BMI body mass index; PA physical activity; MET metabolic-equivalent; TE total energy. SD standard deviation; 
n number; CVD cardiovascular disease; COPD chronic obstructive pulmonary disease. * Fitness data was 
available for n=67,322 participants.  
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Purpose - Walking pace is associated with all-cause and cardiovascular disease (CVD) 24 
mortality. Whether this association extends to other health outcomes and whether it is 25 
independent of total amount of time walked are currently unknown. Therefore, the aim of this 26 
study was to investigate whether usual walking pace is associated with a range of health 27 
outcomes.  28 
 Methods – 318,185 UK Biobank participants (54% women) aged 40-69 years were included. 29 
Walking pace and total walking time were self-reported. The outcomes comprised: all-cause 30 
mortality as well as incidence and mortality from cardiovascular disease (CVD), respiratory 31 
disease and cancer. The associations were investigated using Cox proportional hazard models. 32 
Results - Over a mean of 5.0 years [ranging from 3.3 to 7.8], 5,890 participants died, 18,568 33 
developed CVD, 5,430 respiratory disease and 19,234 cancer. In a fully adjusted model, 34 
compared to slow pace walkers, men and women, respectively, with a brisk pace having lower 35 
risk of mortality from all-causes (HR0.79 [95% CI: 0.69; 0.90] and 0.73 [95% CI: 0.62; 0.85]), 36 
CVD (HR 0.62 [0.50; 0.76] and 0.80 [0.73; 0.88]), respiratory disease (HR 0.58 [95% CI 0.43; 37 
0.78] and 0.66 [0.57; 0.77]), COPD (HR 0.26 [95% 0.12; 0.56] and 0.28 [0.16; 0.49]). No 38 
associations were found for all-cause cancer, colorectal, breast cancer. However, brisk walking 39 
was associated with a higher risk of prostate cancer.  40 
Conclusions: Walking pace is associated with lower risk of a wide range of important health 41 
conditions, independently of overall time spent walking. 42 
Keywords: Mortality; cardiovascular, cancer, walking, walking pace, UK biobank 43 
  44 
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Introduction 45 
Current physical activity guidelines recommend at least 150 minutes of moderate intensity, or 46 
75 minutes high intensity, physical activity per week for all adults [1]. However, around one 47 
third of the adult population worldwide do not meet these recommendations [2]. This 48 
observation highlights the difficulty many people have incorporating physical activity 49 
recommendations into their daily lives in a sustainable way [3]. Lack of time is frequently cited 50 
as the primary barrier to meeting the current recommendations [4].  51 
Walking is the most common form of physical activity that adults perform, and is acceptable 52 
and accessible to almost the entire population [5]. A meta-analysis of randomised controlled 53 
trials found that increased walking time led to increased fitness and decreased body weight, 54 
body mass index (BMI), percentage body fat and systolic blood pressure in adults [6]; all well 55 
known risk factors for premature mortality and morbidity [7]. Previous smaller studies, mostly 56 
conducted on older adults, found an inverse association between objectively assessed walking 57 
pace and all-cause mortality [8-10]. Recent analysis of UK Biobank data found that self-58 
reported walking pace was strongly associated with both all-cause and CVD mortality; indeed 59 
the risk associated with walking at <3 miles per hour, compared with 4 miles per hour, was 60 
stronger than for smoking [7, 11]. However these previous studies did not investigate whether 61 
the associations with walking pace vary with, and are independent of, time spent walking or 62 
whether dose response relationships are present. Furthermore, they did not investigate 63 
associations of walking pace with a wider range of health outcomes, such as respiratory disease 64 
and cancer sub-types.  Therefore, the aim of this study was to investigate, in a large, prospective 65 
population-based cohort of middle age and older adults, the associations between usual walking 66 
pace and a range of cardiovascular, respiratory and cancer health outcomes. A secondary aim 67 
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was to explore whether there were dose relationships or threshold effects, and whether the 68 
associations varied with, and were independent of, total time spent walking.   69 
 70 
METHODS 71 
Between April 2007 and December 2010, UK Biobank recruited 502,628 participants (5.5% 72 
response rate), aged 40-69 years from the general population [12-15]. However, only 318,185 73 
with full data available were included in this study. Participants attended one of 22 assessment 74 
centres across England, Wales and Scotland [12-15] where they completed a touch-screen 75 
questionnaire, had physical measurements taken and provided biological samples, as described 76 
in detail elsewhere [12-15]. All-cause mortality and CVD, respiratory disease, chronic 77 
obstructive pulmonary disease (COPD) and cancer mortality and incidence were the main 78 
outcomes; and walking pace (slow, average and brisk) was the exposure of interest. 79 
Sociodemographic factors (age, sex, ethnicity, employment status and area-based deprivation), 80 
lifestyle factors (smoking status, self-reported discretionary screen time, total physical activity, 81 
grip strength and dietary intake), health related parameters (systolic blood pressure, diabetes, 82 
medication for CVD, and self-reported health rating), body mass index and month of 83 
recruitment were treated as potential confounders. To minimise potential reverse causality, i.e. 84 
those that are less well are not able to walk as fast, all analyses were conducted using landmark 85 
analysis excluding events occurring in the first 2 years of follow-up. Furthermore participants 86 
with baseline medical diagnoses of depression, COPD, chronic asthma, chronic liver diseases, 87 
alcohol problems, substance abuse, eating disorders, schizophrenia, cognitive impartment, 88 
Parkinson’s disease, dementia, chronic pain syndrome, heart diseases, diabetes and cancer were 89 
excluded (n= 71,026). Those who reported being unable to walk (n=1,929) or those who did 90 
not answer these questions were also excluded from the study (n=7,669).  91 
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Procedures 92 
Date of death was obtained from death certificates held by the National Health Service (NHS) 93 
Information Centre (England and Wales) and the NHS Central Register Scotland (Scotland). 94 
Date and cause of hospital admissions were identified via record linkage to Health Episode 95 
Statistics (HES) (England and Wales) and to the Scottish Morbidity Records (SMR01) 96 
(Scotland). Detailed information regarding the linkage procedure can be found at 97 
http://www.ic.nhs.uk/services/medical-research-information-service. At the time of analysis, 98 
mortality data were available up to 31 January 2016. Mortality analysis was therefore censored 99 
at these dates or date of death if this occurred earlier. Hospital admission data were available 100 
until 31 March 2015, resulting in disease specific analyses being censored at this date, or the 101 
date of hospital admission or death if these occurred earlier. Follow-up information on cancer 102 
was obtained via linkage to three routine administrative databases, death certificates, hospital 103 
admissions and cancer registrations, with complete follow-up available until 31 March 2015. 104 
Incident CVD was defined as a hospital admission or death with ICD10 code I60, I61, I63, I64, 105 
I21, I21.4 or I21.9; respiratory disease was defined as ICD10 code J09-J98 or I26-I27 and 106 
chronic obstructive pulmonary disease (COPD) was defined as ICD10 code J44. All-cause 107 
cancer was defined as an ICD code of C0.0-C9.9, D3.7-9 or D4.0-8. Cause-specific cancers 108 
were defined using the following ICD10 codes: breast cancer (C50), prostate cancer (C61), 109 
lung cancer (C34) and colorectal cancer (C18, C19 and C20). 110 
Walking pace was self-reported using a touch-screen questionnaire completed at the baseline 111 
visit. The participants who indicated they were able to walk were asked "How would you 112 
describe your usual walking pace?” and they could choose one of the following: slow pace 113 
defined as <3 miles per hour; average pace defined as 3-4 miles per hour; and brisk pace defined 114 
as >4 miles per hour. Physical activity was based on self-report, using the IPAQ short form, 115 
and total physical activity was computed as the sum of walking, moderate and vigorous 116 
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activity, measured as metabolic equivalents (MET-hours.week-1) [16]. A proxy measure of 117 
total discretionary time spent in screen-related behaviours (TV-viewing and PC-screen) was 118 
calculated. Participants were asked "In a typical day, how many hours do you spend watching 119 
TV, doing PC screening or driving during your leisure time?”, and this combined figure was 120 
used as a proxy for discretionary sedentary measure (expressed as hours per week). Age- and 121 
sex-specific walking categories were derived from total walking minutes (from IPAQ) per day 122 
(cut-off points are presented in Supplementary Table 1). Grip strength was assessed using a 123 
Jamar J00105 hydraulic hand dynamometer and the mean of the three measurements for each 124 
hand were used, grip strength was expressed as kg [17]. Fitness was measured in a subset of 125 
the cohort (n=67,700) using a previously validated 6-minute incremental ramp cycle ergometer 126 
test, as described previously [18].   127 
Dietary information was collected via the Oxford WebQ; a web-based 24-hour recall 128 
questionnaire which was developed specifically for use in large population studies [19, 20]. 129 
Area-based socioeconomic status was derived from postcode of residence, using the Townsend 130 
score [21]. Age was calculated from dates of birth and baseline assessment. Smoking status 131 
was self-reported as never, former or current smoking. Employment status, self-health rating 132 
(excellent, good, average and bad) was self-reported. Medical history (physician diagnosis of 133 
illness) was collected using the self-completed, baseline questionnaire. Height and body weight 134 
were measured by trained nurses during the initial assessment centre visit. Body mass index 135 
(BMI) was calculated as (weight/height2) and the WHO criteria applied to classify BMI into: 136 
underweight <18.5, normal weight 18.5-24.9, overweight 25.0-29.9 and obese ≥30.0 kg.m-2 137 
[22]. Waist circumference was used to derive central obesity:  ≥88 cm for women and ≥102 cm 138 
for men [22]. Body composition (body fat and fat free mass) were measured using bio-139 
impedance (Tanita BC418MA) by trained nurses. Further details of these measurements can 140 
be found in the UK Biobank online protocol (http://www.ukbiobank.ac.uk). 141 
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 142 
Statistical analyses 143 
The associations between walking pace and health outcomes were investigated using separate 144 
Cox-proportional hazard models using slow walking pace as the reference group. Results are 145 
reported as hazard ratios, together with 95% confidence intervals. A hazard ratio for trend was 146 
estimated by fitting walking pace as ordinal variable into the model (0=slow pace, 1=average 147 
pace and 3=brisk pace), the trend hazard ratio indicate the hazard equivalent to moving one 148 
category up in walking pace. The models for disease specific outcomes were conducted 149 
excluding participants with the relevant disease at baseline (as mentioned earlier). Moreover, 150 
we excluded from all analysis individuals who reported comorbidities which could affect 151 
walking pace and time spent walking or those with missing data and those who reported being 152 
unable to walk were excluded from the analyses.  153 
For each outcome, we ran three models included an increasing number of covariates: Model 1 154 
- included month of recruitment and sociodemographic covariates (age, sex, ethnicity, 155 
deprivation index and employment status); Model 2 - was also adjusted for systolic blood 156 
pressure, medication for CVD, self-health rating and BMI categories; and Model 3 - was also 157 
adjusted for smoking, discretionary screen time, dietary intake (alcohol, red meat, processed 158 
meat, oily fish, processed meat and fruit and vegetables), handgrip strength and total physical 159 
activity (this variable was replaced by moderate-to-vigorous physical activity when the 160 
interaction between walking pace and walking time tertiles was investigated).  161 
Tertiles of time spent walking daily were derived for age, sex strata (see Table, Supplemental 162 
Digital Content 1, age- and sex-specific cut-offs). To investigate whether the association 163 
between walking pace and health outcomes differed by time spent walking, a multiplicative 164 
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interaction term between walking pace and walking tertiles was fitted into our models for each 165 
outcome.  166 
The proportional hazards assumption was checked by tests based on Schoenfeld residuals. All 167 
analyses were performed using STATA 14 statistical software (StataCorp LP). 168 
 169 
Ethical Approval  170 
The UK Biobank study was approved by the North West Multi-Centre Research Ethics 171 
Committee and all participants provided written informed consent to participate in the UK 172 
Biobank study.  173 
 174 
Results 175 
The 2-year landmark analyses and exclusion of individuals with major comorbidities at 176 
baseline meant 318,185 participants were included in the analyses. The mean follow-up period 177 
for all-cause and cause-specific mortality was 5.0 years [ranging from 3.3 to 7.8] and 4.1 years 178 
[ranging from 2.4 to 7.0] for cause-specific incidence. Over the follow-up period, 18,568 179 
(5.8%) participants developed CVD, 5,430 (1.7%) respiratory disease and 19,234 (6.0%) 180 
cancer, and 5,890 (1.9%) participants died (1,761 (0.6%) from CVD, 878 (0.3%) from 181 
respiratory disease and 3,687 (1.2%) from cancer.  182 
 183 
The characteristics of participants by walking pace category are summarised in Table 1. 184 
Compared with individuals who walked slowly, brisk walkers were less deprived and had a 185 
lower prevalence of smoking and obesity. They had lower BMI, waist circumference and 186 
percentage body fat, and lower intake of processed and red meat, but higher intake of alcohol, 187 
 9 
 
oily fish, fruit and vegetables. They also had higher levels of physical activity, fitness and 188 
muscle strength and lower levels of discretionary screen time (Table 1). The cohort 189 
characteristics stratified by sex are presented (see Table, Supplemental Digital Content 2, 190 
baseline characteristics by walking pace in women and Table, Supplemental Digital Content 3, 191 
baseline characteristics by walking pace in men).  192 
 193 
Overall, our analyses taking detailed account of the above confounders, suggest that both 194 
average and brisk walking pace were associated with a lower hazard for all-cause, CVD, 195 
respiratory disease and COPD mortality in both men and women, compared to slow walking 196 
pace (Figure 1). The hazard ratios for health outcomes mortality, both minimally and fully 197 
adjusted, are presented (see Table, Supplemental Digital Content 4, walking pace and mortality 198 
in women, and Table, Supplemental Digital Content 5, walking pace and mortality in men). In 199 
summary, the fully adjusted hazard per one category increment in walking pace was 0.91 [95% 200 
CI: 0.85; 0.98] and 0.90 [95% CI: 0.85; 0.95], for all-cause mortality in women and men, 201 
respectively. The magnitude of the association was stronger for CVD (Women 0.71 [95% CI: 202 
0.61; 0.83]; Men 0.81 [95% CI: 0.73; 0.90]), respiratory (Women 0.72 [95% CI: 0.58; 0.89]; 203 
Men 0.76 [95% CI: 0.66; 0.88]),  and COPD (Women 0.19 [95% CI: 0.08; 0.45]; Men 0.49 204 
[95% CI: 0.33; 0.73]), compared to all-cause mortality per one category increment in walking 205 
pace, as shown in Figure 1).  206 
 207 
Similar results were observed for cause-specific incidence, except for prostate cancer for a 208 
higher hazard was observed in those reporting either average or brisk walking pace (Figure 2). 209 
The hazard ratios for health outcomes incidence, both minimally and fully adjusted, are 210 
presented (see Table, Supplemental Digital Content 6, walking pace and incidence in women, 211 
and Table, Supplemental Digital Content 7, walking pace and incidence in men).  In our fully 212 
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adjusted model, the hazards per one category increment in walking pace were 0.92 [95% CI: 213 
0.88; 0.96] and 0.94 [95% CI: 0.91; 0.97], for CVD incidence in women and men, respectively. 214 
Similar trend swere observed for all-respiratory disease incidence (Women 0.84 [95% CI: 0.78; 215 
0.90]; Men 0.84 [95% CI: 0.79; 0.89]), and COPD (Women 0.54 [95% CI: 0.42; 0.70]; Men 216 
0.60 [95% CI: 0.48; 0.74]) per one category increment in walking pace, as shown in figure 2. 217 
However, the hazard for prostate cancer risk was 1.10 [95% CI: 1.02; 1.19]) per one category 218 
increment in walking pace.  219 
 220 
When the associations between walking pace and health outcomes were stratified by walking 221 
time tertiles (expressed as min.day-1), significant interactions were found for all-cause mortality 222 
but not for CVD, respiratory disease, and all-cancer incidence and mortality (Figure 3 and 4 223 
and see Table, Supplemental Digital Content 8, walking pace tertiles and mortality in women, 224 
and Table, Supplemental Digital Content 9, walking pace tertiles and mortality in men)). Our 225 
findings show that, compared to those reporting brisk walking pace and who were classified in 226 
the higher walking time category, individuals who reported slow walking pace were at higher 227 
risk for all-cause mortality if they were classified in the middle or lower walking time 228 
categories. However, for CVD and respiratory incidence and mortality, those who reported a 229 
slow pace were at higher risk for these health outcomes regardless if they were classified in the 230 
higher, middle or lower walking time categories. Interestingly, those who were in the middle 231 
or lower walking time tertiles were not at higher risk for these outcomes if they reported brisk 232 
walking pace (Figure 3 and 4). These trends were not observed for cancer mortality or 233 
incidence. All these findings were independent of major confounding factors.        234 
 235 
DISCUSSION 236 
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Usual walking pace was associated with a range of health outcomes that extended beyond CVD 237 
and all-cause mortality, to all-respiratory diseases and COPD in both men and women. The 238 
associations demonstrated were independent of measured confounders; most notably total 239 
physical activity. Our findings also show that those reporting normally walking at a slow pace 240 
had higher hazard for all-cause mortality and CVD and respiratory incident and mortality 241 
regardless the time spent walking. Future research, with appropriately designed randomised-242 
controlled trials, is needed to determine if the current observations reflect a causal association 243 
and if so these findings could have import implications for physical activity recommendations.  244 
 245 
Comparison with previous studies 246 
The current finding of an inverse association between self-reported usual walking pace and all-247 
cause and CVD mortality is consistent with previous studies [8, 23-31]. The majority of these 248 
previous studies have, however, been carried out in older people and looked at maximal 249 
walking pace [23, 24, 31-33] making the findings less relevant for the general population. 250 
Previous studies carried out over a wider age range have generally been small or modest in size 251 
(1,255 – 38,981 participants) [9, 25, 26, 30] and have involved studies of recreational walkers 252 
[25] and CVD patients [26, 30]. Two recent studies by Yates et al.,[11] and Ganna and 253 
Ingelsson [7], using UK Biobank data found that walking pace was a stronger predictor of all-254 
cause and CVD mortality, indicating that this measure, that can be simply obtained by verbal 255 
interviews without physical examination, is a stronger predictor of mortality. The current study, 256 
in a well characterised and large cohort, confirms that a slow walking pace is associated with 257 
an increased all-cause and CVD mortality and extends these findings with novel data to 258 
demonstrate that an average (3-4 miles.hour-1) or brisk walking pace (>4 miles.hour-1) is 259 
associated with a lower risk of COPD and all-cancer mortality whilst a brisk walking pace is 260 
associated with a lower risk of lung cancer mortality and incidence. Surprisingly an average 261 
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and brisk walking pace were also associated with an increased risk of prostate cancer incidence, 262 
but not mortality. Previously positive associations between prostate cancer incidence and 263 
physical activity (or fitness a surrogate of total physical activity) has been reported in some 264 
[34, 35] but not all [36] studies. The exact reasons behind these observations are unknown, but 265 
differences in health-seeking behaviours, may be a contributing factor [34]. For example, it has 266 
been postulated that health-conscious men (who are more likely to walk briskly), may be more 267 
likely to attend screening or report symptoms leading to increased detection of early cancers 268 
and improved prognosis [34]. 269 
We have extended the findings that slow walking pace is associated with increased risk of poor 270 
health outcomes by also demonstrating, that this association is present regardless of the amount 271 
of total time spent walking. Not only were those reporting a slow walking pace at higher risk 272 
for all-cause, CVD and respiratory incidence and mortality compared to those reporting brisk 273 
walking pace but the incidence and mortality risk was the same in those reporting brisk walking 274 
across all three walking time categories. Taken together, this indicates that the pace at which 275 
walking is habitually carried out maybe more important for health outcomes than the total 276 
amount of time spent walking, although it is worth pointing out that whilst we have carried out 277 
robust statistical adjustment here we cannot rule out reverse causality (i.e. those that are less 278 
well are not able to walk as fast) even though we tried to minimise this in our landmark analyses 279 
and by taking out all individuals with long standing illness. These findings are, however, 280 
similar to those reported in the Caerphilly study where only leisure activity classified as heavy 281 
or vigorous was associated with a reduced risk of CVD mortality [37], although this study was 282 
confined to middle-aged men and included all forms of activity, with the current study focused 283 
on walking only. Appropriately designed randomised controlled trials are needed to determine 284 
if these findings are causal.  285 
 286 
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Implications of findings 287 
Walking is frequently recommended as a tool to increase physical activity levels as it is free 288 
and generally accessible to all, but currently the primary focus has been to increase the time 289 
spent or the number of steps walked [38, 39] with the pace of walking often receiving less 290 
focus. If future trials confirm the findings of the current study this may indicate that whilst 291 
strategies to increase total walking time, which is currently the primary focus, will be of benefit 292 
it may be prudent to also ensure promotion of a brisk walking pace, where the individual is 293 
capable, to further enhance the benefits of walking. On the other hand, if these findings are 294 
shown not to be causal, the data indicates that self-reported walking pace may be a useful tool 295 
too indicate sub-clinical illness which may progress to poorer health outcomes.  296 
 297 
Strengths and limitations 298 
The UK Biobank is reasonably representative of the general population in terms of age, sex, 299 
ethnicity and socioeconomic status but is unrepresentative in terms of lifestyle [40]. Therefore, 300 
caution is needed in generalising summary statistics to the general population, but estimates of 301 
the magnitude of the associations are, nevertheless, generalisable. Participants were more likely 302 
to be older, to be women, and to live in less socioeconomically deprived areas; were less likely 303 
to be obese, to smoke, or to drink alcohol on a daily basis; and had fewer self-reported health 304 
outcomes. Rates of all-cause mortality and incidence of cancer were also lower.[41, 42]. This 305 
does not detract from the ability to generalize estimates of the magnitude of associations. Our 306 
study benefited from a very large number of participants, recruited from the general population, 307 
across the whole of the UK. We had sufficient power to undertake subgroup analyses by sex, 308 
which overcomes limitations from previous evidence. Reverse causality is possible in any 309 
observational study; however, when participants with existing disease diagnosed at baseline 310 
were removed from the analysis the associations remained significant. Moreover, our results 311 
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were broadly similar after a landmark analysis was conducted removing all events that occurred 312 
within the first two years of follow up. Walking pace was self-reported and, to our knowledge, 313 
the question used has not previously been validated. Although prevalent disease and 314 
comorbidities at baseline were self-reported, these self-reports were of physician diagnosed 315 
disease.   316 
 317 
In conclusion, the current data has demonstrated that, irrespective of total walking time, a faster 318 
walking pace is associated with lower risk of a wide range of health outcomes. The findings 319 
require determination of causality in appropriately designed trials, but could have important 320 
implications for physical activity recommendations. They tentatively imply guidelines should 321 
encourage people to increase their walking pace (if low to begin with), rather than simply 322 
focusing on total time spent walking. As lack of time is the most commonly cited barrier to 323 
increasing activity levels; brisk walking of shorter duration may be easier to accommodate into 324 
busy schedules and the benefits may be greatest among those failing to meet the current 325 
recommendations. 326 
 327 
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FIGURE LEGENDS 486 
 487 
Figure 1. Cox proportional hazard models of the association between walking pace and 488 
all- and cause-specific mortality by sex. 489 
Data presented as adjusted hazard ratio (HR) and its 95% confidence interval (95% CI) by 490 
walking pace category. Slow walking pace was used as reference group for these analysis. 491 
Trend hazard ratio indicate the change in the hazard per one category change in walking pace.  492 
All analyses were conducted using a 2-years landmark analyses and by excluding participants 493 
with major diseases at baseline. Analyses were adjusted for month of recruitment, age, 494 
deprivation index, employment status, ethnicity, systolic blood pressure, medication for CVD, 495 
self-health rating, BMI categories, smoking, discretionary screen time, dietary intake (alcohol, 496 
red meat, processed meat, oily fish, processed meat and fruit and vegetables), handgrip strength 497 
and total physical activity.   498 
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 499 
 500 
Figure 2. Cox proportional hazard models of the association between walking pace and 501 
cause-specific incidence by sex. 502 
Data presented as adjusted hazard ratio (HR) and its 95% confidence interval (95% CI) by 503 
walking pace category. Slow walking pace was used as reference group for these analysis. 504 
Trend hazard ratio indicate the change in the hazard per one category change in walking pace.  505 
All analyses were conducted using a 2-years landmark analyses and by excluding participants 506 
with major diseases at baseline. Analyses were adjusted for month of recruitment, age, 507 
deprivation index, employment status, ethnicity, systolic blood pressure, medication for CVD, 508 
self-health rating, BMI categories, smoking, discretionary screen time, dietary intake (alcohol, 509 
red meat, processed meat, oily fish, processed meat and fruit and vegetables), handgrip strength 510 
and total physical activity.   511 
 512 
 513 
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 514 
Figure 3. Hazard ratio for all- and cause-specific mortality by walking pace and total 515 
walking time tertiles 516 
Data presented as adjusted hazard ratio (HR) and its 95% confidence interval (95% CI) by 517 
walking pace and total walking time tertiles. Individuals who reported brisk walking pace and 518 
higher levels of walking time were used as reference group.  Analyses were conducted using a 519 
2 years-landmark analyses and all participants with comorbidities at baseline were excluded 520 
from the analyses. The analyses were adjusted for month of recruitment, age, deprivation index, 521 
employment status, ethnicity, systolic blood pressure, medication for CVD, self-health rating, 522 
BMI categories, smoking, discretionary screen time, dietary intake (alcohol, red meat, 523 
processed meat, oily fish, processed meat and fruit and vegetables), handgrip strength and 524 
moderate to vigorous physical activity. 525 
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Figure 4. Hazard ratio for cause-specific incidence by walking pace and total walking 527 
time tertiles 528 
Data presented as adjusted hazard ratio (HR) and its 95% confidence interval (95% CI) by 529 
walking pace and total walking time tertiles. Individuals who reported brisk walking pace and 530 
higher levels of walking time were used as reference group.  Analyses were conducted using a 531 
2 years-landmark analyses and all participants with comorbidities at baseline were excluded 532 
from the analyses. The analyses were adjusted for month of recruitment, age, deprivation index, 533 
employment status, ethnicity, systolic blood pressure, medication for CVD, self-health rating, 534 
BMI categories, smoking, discretionary screen time, dietary intake (alcohol, red meat, 535 
processed meat, oily fish, processed meat and fruit and vegetables), handgrip strength and 536 
moderate to vigorous physical activity. 537 
Table 1. Cohort characteristics by walking pace 
  Walking pace 
 Overall  Slow  
(<3 miles.h-1) 
Average 
(3-4 miles.h-1) 
Brisk  
(>4 miles.h-1) 
Socio-demographics     
Total n 318,185 14,793 164,236 139,156 
Sex (females), n(%) 174,006 (54.7) 8,483 (57.3) 89,847 (54.7) 75,676 (54.4) 
Age (years), mean (SD) 56.0 (8.14) 58.2 (7.73) 56.8 (8.08) 54.9 (8.11) 
Deprivation index tertile, n (%) 
   Lower (Less deprived) 
   Middle 
   Higher (Most deprived) 
 
109,884 (34.5) 
108,397 (34.1) 
99,904 (31.4) 
 
3,511 (23.7) 
4,465 (30.2) 
6,817 (46.1) 
 
55,566 (33.8) 
56,017 (34.1) 
52,653 (32.1) 
 
50,807 (36.5) 
47,915 (34.4) 
40,434 (29.1) 
Ethnicity  
   Whites 
   Others/mixed 
   South Asians 
   Blacks 
   Chinese    
 
302,067 (94.9) 
4,614 (1.5) 
5,655 (1.8) 
4,871 (1.5) 
978 (0.3) 
 
13,090 (88.5) 
425 (2.9) 
721 (4.9) 
447 (3.0) 
110 (0.7) 
 
154,468 (94.1) 
2,607 (1.6) 
3,595 (2.2) 
2,930 (1.8) 
636 (0.3) 
 
134,509 (96.7) 
1,582 (1.1) 
1,339 (1.0) 
1,494 (1.1) 
232 (0.1) 
Employment status  
   Employed 
   Retired 
   Looking after home/family 
   Unable to work 
   Unemployed 
   Voluntary work 
   Student  
 
193,277 (60.7) 
102,224 (32.1) 
9,524 (3.0) 
5,588 (1.8) 
5,133 (1.6) 
1,518 (0.5) 
921 (0.3) 
 
5,521 (37.3) 
6,238 (42.2) 
476 (3.2) 
2,090 (14.1) 
352 (2.4) 
60 (0.4) 
56 (0.4) 
 
94,593 (57.6) 
58,070 (35.4) 
4,905 (3.0) 
2,572 (1.6) 
2,899 (1.8) 
760 (0.4) 
437 (0.2) 
 
93,163 (67.0) 
37,916 (27.3) 
4,143 (3.0) 
926 (0.6) 
1,882 (1.3) 
698 (0.5) 
428 (0.3) 
Smoking status, n (%) 
   Never 
   Previous 
   Current  
 
180,226 (56.6) 
107,853 (33.9) 
30,106 (9.5) 
 
7,256 (49.1) 
5,344 (36.1) 
2,193 (14.8) 
 
90,937 (55.4) 
56,856 (34.6) 
16,443 (10.0) 
 
82,033 (59.0) 
45,653 (32.8) 
11,470 (8.2) 
Obesity-related markers     
BMI (kg.m-2), mean (SD) 27.0 (4.50) 30.9 (6.26) 27.8 (4.55) 25.7 (3.71) 
BMI Categories, n (%) 
   Underweight  (<18.5 kg.m-2) 
   Normal weight (18.5-24.9 kg.m-2) 
   Overweight (25.0 to 29.9 kg.m-2) 
   Obese (≥30.0 kg.m-2) 
 
1,594 (0.5) 
111,470 (35.0) 
137,007 (43.1) 
68,114 (21.4) 
 
51 (0.3) 
2,309 (15.6) 
5,019 (33.9) 
7,414 (50.2) 
 
549 (0.3) 
45,855 (27.9) 
73,907 (45.0) 
43,925 (26.8) 
 
994 (0.7) 
63,306 (45.5) 
58,081 (41.7) 
16,775 (12.1) 
Waist Circumference (cm), mean 
(SD) 
89.2 (13.0) 98.3 (14.9) 91.1 (12.9) 86.0 (11.9) 
Central Obesity, n (%) 96,080 (30.2) 8,861 (59.9) 60,191 (36.7) 27,028 (19.4) 
% Body fat, mean (SD) 30.9 (8.43) 36.0 (9.25) 32.1 (8.41) 28.9 (7.84) 
Fitness and Physical activity     
Fitness (METs), mean (SD) 9.72 (2.77) 8.33 (2.48) 9.32 (2.67) 10.3 (2.79) 
Grip strength (Kg), mean (SD) 31.1 (10.9) 26.4 (11.0) 30.5 (10.9) 32.3 (10.8) 
Time spent walking (min.day-1), 
mean (SD) 
53.2 (56.2) 43.3 (50.0) 53.5 (57.3) 53.9 (55.5) 
Moderate intensity PA (min.day-1), 
mean (SD) 
45.0 (54.8) 40.9 (52.0) 45.1 (55.1) 45.2 (54.7) 
Vigorous intensity PA (min.day-1), 
mean (SD) 
21.1 (27.4) 18.8 (28.2) 20.3 (27.4) 22.1 (27.3) 
Total PA (METs.min.week-1), mean 
(SD) 
2,860.7 
(3,052.4) 
2,053.6 
(2,503.5) 
2,774.4 
(3,012.1) 
3,048.4 
(3,133.2) 
Physical inactivity, n (%) 39,360 (17.1) 2,214 (25.5) 21,231 (18.3) 15,915 (15.2) 
TV-viewing (h.day-1) 2.67 (1.49) 3.45 (1.96) 2.83 (1.49) 2.40 (1.37) 
Dietary intakes     
Alcohol intake (% of TE), mean (SD) 5.27 (6.50) 4.30 (6.68) 5.14 (6.59) 5.47 (6.39) 
Fruit & Vegetables intake 
(portion.day-1), mean (SD)  
338.4 (1.93.0) 328.8 (216.9) 327.4 (190.8) 352.4 (192.1) 
Oily fish (portion.day-1), mean (SD) 1.66 (0.92) 1.57 (0.98) 1.63 (0.92) 1.71 (0.92) 
Processed meat intake (portion.day-
1), mean (SD) 
1.84 (1.06) 1.97 (1.12) 1.91 (1.05) 1.76 (1.06) 
Red meat intake (portion.day-1), 
mean (SD) 
2.08 (1.41) 2.23 (1.63) 2.13 (1.42) 2.00 (1.37) 
Health status     
Diabetes, n (%) 12,449 (3.9) 1,771 (12.0) 7,665 (4.7) 3,013 (2.2) 
Systolic blood pressure (mmHg), 
mean (SD) 
137.6 (18.6) 140.3 (18.7) 138.9 (18.7) 135.9 (18.4) 
CVD medication, n (%) 73,389 (23.1) 6,399 (43.2) 43,223 (26.3) 23,767 (17.1) 
Health self-rating, n (%) 
   Excellent  
   Good  
   Fair 
   Poor 
 
61,704 (19.4) 
194,547 (61.1) 
54,972 (17.3) 
6,962 (2.2) 
 
554 (3.8) 
5,374 (36.3) 
6,224 (42.1) 
2,641 (17.8) 
 
23,028 (14.0) 
103,870 (63.2) 
34,116 (20.8) 
3,222 (2.0) 
 
38,122 (27.4) 
85,303 (61.3) 
14,632 (10.5) 
1,099 (0.8) 
  
BMI body mass index; PA physical activity; MET metabolic-equivalent; TE total energy. SD standard deviation; 
n number; CVD cardiovascular disease; COPD chronic obstructive pulmonary disease. * Fitness data was 
available for n=67,322 participants.  
 
